Will centralized drug procurement policy improve enterprises’ total factor productivity?
Against the backdrop of China’s healthcare reform challenges in drug pricing, this study investigates the impact of the National Centralized Drug Procurement (NCDP) policy implemented in 2018. Employing Difference-in-Differences (DID) methodology on quarterly data from A-share listed pharmaceutical...
Saved in:
| Main Authors: | Xin Li, Ran Tao, Wenxue Zou, Yuning Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1504342/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge, attitudes, and practices of outpatients regarding National centralized drug procurement policy: a multicenter cross-sectional study in North China
by: Yijie Ma, et al.
Published: (2025-07-01) -
Changes in antibiotic use associated with the National Centralized Drug Procurement policy in China from 2019 to 2023
by: Fanyu Lin, et al.
Published: (2025-07-01) -
Healthcare professionals’ knowledge, attitudes, and practices regarding China’s National Centralized Drug Procurement policy: a cross-sectional study in Shaanxi Province
by: Qian Shen, et al.
Published: (2025-08-01) -
Comparative study on government subsidy models for competitive drug supply chains under centralized procurement policy
by: Yan Wen, et al.
Published: (2025-03-01) -
Increased consumption of cardiovascular drugs under volume-based procurement (VBP) policy: demand release or assessment inducing?
by: Ying Yang, et al.
Published: (2024-12-01)